Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > MD & A and Interim Financials Out

<< Previous

Bullboard Posts

Next >>

Comment by Camaronion Apr 19, 2011 5:41pm

235 Views

Post# 18456503

RE: MD & A and Interim Financials Out

There is nothing can be done when an seller sells (liquidates) into the market for a set number of shares "at market" price as opposed to a set price. Small volume ends up chasing the bids down the rabbit hold. That is what happened today.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec